North America Precision Diagnostics Market Size, Share & Trends Analysis Report By End-use, By Type, By Application (Oncology, Respiratory Diseases, CNS Disorders, Immunology, Skin Diseases, Genetic Diseases, and Others), By Country and Growth Forecast, 2024 - 2031

The North America Precision Diagnostics Market would witness market growth of 17.5% CAGR during the forecast period (2024-2031).

The US market dominated the North America Precision Diagnostics Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $16,362.9 million by 2031. The Canada market is experiencing a CAGR of 19.7% during (2024 - 2031). Additionally, The Mexico market is exhibiting a CAGR of 20.3% during (2024 - 2031).

Precision diagnostics refers to a sophisticated approach in healthcare that involves using advanced technologies and methodologies to diagnose diseases accurately at a molecular or genetic level. This approach identifies specific biomarkers, genetic mutations, or other molecular signatures unique to a patient's condition.

Moreover, Precision diagnostics aims to tailor medical treatments and interventions based on these individual characteristics, thereby optimizing therapeutic outcomes and minimizing potential side effects.

With higher incidences of cancer, there is a growing demand for advanced diagnostic technologies. This includes genetic testing, next-generation sequencing (NGS), and molecular diagnostics to accurately diagnose and subtype different types of cancer prevalent in the Mexican population. According to All.Can, cancer rank as the third leading cause of death in Mexico, with over 195,000 new cases reported in 2020. The most prevalent types included breast (29,929 cases), prostate (26,742 cases), thyroid (11,227 cases), colon (11,191 cases), and cervical cancer (9,439 cases).

Free Valuable Insights: The Precision Diagnostics Market is Predict to reach USD 55.03 Billion by 2031, at a CAGR of 18.0%

Based on End-use, the market is segmented into Clinical Laboratories, Hospitals, and Others. Based on Type, the market is segmented into Genetic Tests, Esoteric Tests, Direct to Consumer Tests, and Others. Based on Application, the market is segmented into Oncology, Respiratory Diseases, CNS Disorders, Immunology, Skin Diseases, Genetic Diseases, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

• Abbott Laboratories
• F.Hoffmann-La Roche Ltd.
• Siemens Healthineers AG (Siemens AG)
• Thermo Fisher Scientific, Inc.
• Danaher Corporation
• Agilent Technologies, Inc.
• BioMerieux S.A.
• Becton, Dickinson and Company
• Qiagen N.V
• Hologic, Inc.

North America Precision Diagnostics Market Report Segmentation

By End-use

• Clinical Laboratories
• Hospitals
• Others

By Type

• Genetic Tests
• Esoteric Tests
• Direct to Consumer Tests
• Others

By Application

• Oncology
• Respiratory Diseases
• CNS Disorders
• Immunology
• Skin Diseases
• Genetic Diseases
• Others

By Country

• US
• Canada
• Mexico
• Rest of North America

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Precision Diagnostics Market, by End-use
1.4.2 North America Precision Diagnostics Market, by Type
1.4.3 North America Precision Diagnostics Market, by Application
1.4.4 North America Precision Diagnostics Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges

Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2020-2024)
4.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2021, Jul – 2024, May) Leading Players
4.4 Porter Five Forces Analysis

Chapter 5. North America Precision Diagnostics Market by End-use
5.1 North America Clinical Laboratories Market by Country
5.2 North America Hospitals Market by Country
5.3 North America Others Market by Country

Chapter 6. North America Precision Diagnostics Market by Type
6.1 North America Genetic Tests Market by Country
6.2 North America Esoteric Tests Market by Country
6.3 North America Direct to Consumer Tests Market by Country
6.4 North America Others Market by Country

Chapter 7. North America Precision Diagnostics Market by Application
7.1 North America Oncology Market by Country
7.2 North America Respiratory Diseases Market by Country
7.3 North America CNS Disorders Market by Country
7.4 North America Immunology Market by Country
7.5 North America Skin Diseases Market by Country
7.6 North America Genetic Diseases Market by Country
7.7 North America Others Market by Country

Chapter 8. North America Precision Diagnostics Market by Country
8.1 US Precision Diagnostics Market
8.1.1 US Precision Diagnostics Market by End-use
8.1.2 US Precision Diagnostics Market by Type
8.1.3 US Precision Diagnostics Market by Application
8.2 Canada Precision Diagnostics Market
8.2.1 Canada Precision Diagnostics Market by End-use
8.2.2 Canada Precision Diagnostics Market by Type
8.2.3 Canada Precision Diagnostics Market by Application
8.3 Mexico Precision Diagnostics Market
8.3.1 Mexico Precision Diagnostics Market by End-use
8.3.2 Mexico Precision Diagnostics Market by Type
8.3.3 Mexico Precision Diagnostics Market by Application
8.4 Rest of North America Precision Diagnostics Market
8.4.1 Rest of North America Precision Diagnostics Market by End-use
8.4.2 Rest of North America Precision Diagnostics Market by Type
8.4.3 Rest of North America Precision Diagnostics Market by Application

Chapter 9. Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Product Launches and Product Expansions:
9.2.6 SWOT Analysis
9.3 Siemens Healthineers AG (Siemens AG)
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.5.2 Product Launches and Product Expansions:
9.3.5.3 Acquisition and Mergers:
9.3.6 SWOT Analysis
9.4 Thermo Fisher Scientific, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.6 SWOT Analysis
9.5 Danaher Corporation
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.6 SWOT Analysis
9.6 Agilent Technologies, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.6.5.2 Product Launches and Product Expansions:
9.6.6 SWOT Analysis
9.7 BioMerieux S.A.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.5.2 Acquisition and Mergers:
9.7.6 SWOT Analysis
9.8 Becton, Dickinson, and Company
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.8.5 SWOT Analysis
9.9 Qiagen N.V.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional Analysis
9.9.4 Research & Development Expenses
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.5.2 Product Launches and Product Expansions:
9.9.6 SWOT Analysis
9.10. Hologic, Inc.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 SWOT Analysis

TABLE 1 North America Precision Diagnostics Market, 2020 - 2023, USD Million
TABLE 2 North America Precision Diagnostics Market, 2024 - 2031, USD Million
TABLE 3 Partnerships, Collaborations and Agreements – Precision Diagnostics Market
TABLE 4 Product Launches And Product Expansions – Precision Diagnostics Market
TABLE 5 Acquisition and Mergers – Precision Diagnostics Market
TABLE 6 North America Precision Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 7 North America Precision Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 8 North America Clinical Laboratories Market by Country, 2020 - 2023, USD Million
TABLE 9 North America Clinical Laboratories Market by Country, 2024 - 2031, USD Million
TABLE 10 North America Hospitals Market by Country, 2020 - 2023, USD Million
TABLE 11 North America Hospitals Market by Country, 2024 - 2031, USD Million
TABLE 12 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 13 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 14 North America Precision Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 15 North America Precision Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 16 North America Genetic Tests Market by Country, 2020 - 2023, USD Million
TABLE 17 North America Genetic Tests Market by Country, 2024 - 2031, USD Million
TABLE 18 North America Esoteric Tests Market by Country, 2020 - 2023, USD Million
TABLE 19 North America Esoteric Tests Market by Country, 2024 - 2031, USD Million
TABLE 20 North America Direct to Consumer Tests Market by Country, 2020 - 2023, USD Million
TABLE 21 North America Direct to Consumer Tests Market by Country, 2024 - 2031, USD Million
TABLE 22 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 23 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 24 North America Precision Diagnostics Market by Application, 2020 - 2023, USD Million
TABLE 25 North America Precision Diagnostics Market by Application, 2024 - 2031, USD Million
TABLE 26 North America Oncology Market by Country, 2020 - 2023, USD Million
TABLE 27 North America Oncology Market by Country, 2024 - 2031, USD Million
TABLE 28 North America Respiratory Diseases Market by Country, 2020 - 2023, USD Million
TABLE 29 North America Respiratory Diseases Market by Country, 2024 - 2031, USD Million
TABLE 30 North America CNS Disorders Market by Country, 2020 - 2023, USD Million
TABLE 31 North America CNS Disorders Market by Country, 2024 - 2031, USD Million
TABLE 32 North America Immunology Market by Country, 2020 - 2023, USD Million
TABLE 33 North America Immunology Market by Country, 2024 - 2031, USD Million
TABLE 34 North America Skin Diseases Market by Country, 2020 - 2023, USD Million
TABLE 35 North America Skin Diseases Market by Country, 2024 - 2031, USD Million
TABLE 36 North America Genetic Diseases Market by Country, 2020 - 2023, USD Million
TABLE 37 North America Genetic Diseases Market by Country, 2024 - 2031, USD Million
TABLE 38 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 39 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 40 North America Precision Diagnostics Market by Country, 2020 - 2023, USD Million
TABLE 41 North America Precision Diagnostics Market by Country, 2024 - 2031, USD Million
TABLE 42 US Precision Diagnostics Market, 2020 - 2023, USD Million
TABLE 43 US Precision Diagnostics Market, 2024 - 2031, USD Million
TABLE 44 US Precision Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 45 US Precision Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 46 US Precision Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 47 US Precision Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 48 US Precision Diagnostics Market by Application, 2020 - 2023, USD Million
TABLE 49 US Precision Diagnostics Market by Application, 2024 - 2031, USD Million
TABLE 50 Canada Precision Diagnostics Market, 2020 - 2023, USD Million
TABLE 51 Canada Precision Diagnostics Market, 2024 - 2031, USD Million
TABLE 52 Canada Precision Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 53 Canada Precision Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 54 Canada Precision Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 55 Canada Precision Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 56 Canada Precision Diagnostics Market by Application, 2020 - 2023, USD Million
TABLE 57 Canada Precision Diagnostics Market by Application, 2024 - 2031, USD Million
TABLE 58 Mexico Precision Diagnostics Market, 2020 - 2023, USD Million
TABLE 59 Mexico Precision Diagnostics Market, 2024 - 2031, USD Million
TABLE 60 Mexico Precision Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 61 Mexico Precision Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 62 Mexico Precision Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 63 Mexico Precision Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 64 Mexico Precision Diagnostics Market by Application, 2020 - 2023, USD Million
TABLE 65 Mexico Precision Diagnostics Market by Application, 2024 - 2031, USD Million
TABLE 66 Rest of North America Precision Diagnostics Market, 2020 - 2023, USD Million
TABLE 67 Rest of North America Precision Diagnostics Market, 2024 - 2031, USD Million
TABLE 68 Rest of North America Precision Diagnostics Market by End-use, 2020 - 2023, USD Million
TABLE 69 Rest of North America Precision Diagnostics Market by End-use, 2024 - 2031, USD Million
TABLE 70 Rest of North America Precision Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 71 Rest of North America Precision Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 72 Rest of North America Precision Diagnostics Market by Application, 2020 - 2023, USD Million
TABLE 73 Rest of North America Precision Diagnostics Market by Application, 2024 - 2031, USD Million
TABLE 74 Key Information – Abbott Laboratories
TABLE 75 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 76 Key Information – Siemens Healthineers AG
TABLE 77 Key Information – Thermo Fisher Scientific, Inc.
TABLE 78 Key Information – Danaher Corporation
TABLE 79 key Information – Agilent Technologies, Inc.
TABLE 80 Key information – BioMerieux S.A.
TABLE 81 Key Information – Becton, Dickinson and Company
TABLE 82 Key Information – Qiagen N.V.
TABLE 83 Key Information – Hologic, Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 North America Precision Diagnostics Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Precision Diagnostics Market
FIG 4 KBV Cardinal Matrix
FIG 5 Key Leading Strategies: Percentage Distribution (2020-2024)
FIG 6 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2021, Jul – 2024, May) Leading Players
FIG 7 Porter’s Five Forces Analysis – Precision Diagnostics Market
FIG 8 North America Precision Diagnostics Market share by End-use, 2023
FIG 9 North America Precision Diagnostics Market share by End-use, 2031
FIG 10 North America Precision Diagnostics Market by End-use, 2020 - 2031, USD Million
FIG 11 North America Precision Diagnostics Market share by Type, 2023
FIG 12 North America Precision Diagnostics Market share by Type, 2031
FIG 13 North America Precision Diagnostics Market by Type, 2020 - 2031, USD Million
FIG 14 North America Precision Diagnostics Market share by Application, 2023
FIG 15 North America Precision Diagnostics Market share by Application, 2031
FIG 16 North America Precision Diagnostics Market by Application, 2020 - 2031, USD Million
FIG 17 North America Precision Diagnostics Market share by Country, 2023
FIG 18 North America Precision Diagnostics Market share by Country, 2031
FIG 19 North America Precision Diagnostics Market by Country, 2020 - 2031, USD Million
FIG 20 SWOT Analysis: Abbott Laboratories
FIG 21 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
FIG 22 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 23 Recent strategies and developments: Siemens Healthineers AG
FIG 24 SWOT Analysis: Siemens Healthineers AG
FIG 25 SWOT Analysis: Thermo Fisher Scientific, Inc.
FIG 26 SWOT Analysis: Danaher Corporation
FIG 27 Recent strategies and developments: Agilent Technologies, Inc.
FIG 28 Swot Analysis: Agilent Technologies, Inc.
FIG 29 Recent strategies and developments: BioMerieux S.A.
FIG 30 Swot Analysis: BioMerieux S.A.
FIG 31 SWOT Analysis: Becton, Dickinson and company
FIG 32 Recent strategies and developments: QIAGEN N.V
FIG 33 Swot Analysis: Qiagen N.V.
FIG 34 Swot Analysis: Hologic, Inc.